Remicade® Does Not Abolish the Need for Surgery in Fistulizing Crohn’s Disease
✍ Scribed by LisaS. Poritz; WilliamA. Rowe; WalterA. Koltun
- Publisher
- Springer
- Year
- 2002
- Tongue
- English
- Weight
- 382 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0012-3706
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background: Nowadays anti-TNF-␣ antibodies are used for the treatment of perianal Crohn's disease (CD). Nevertheless, this treatment is effective in only a part of these patients and recent studies suggested a role for other cytokines in chronic bowel inflammation. The aim of this study was to asses
Background: Our primary aim was to determine if the rate of small bowel resection (SBR) has declined over time among Crohn's disease (CD) patients seen at a single academic institution. A secondary aim was to establish whether the indication for surgery has changed. ## Methods: Patients with a pr
Background: Antibodies directed against Saccharomyces cerevisiae (ASCA), perinuclear components of neutrophils (pANCA), and porin protein C of Escherichia coli (anti-OmpC) are reported to be associated with disease phenotype and may be of diagnostic importance in inflammatory bowel disease (IBD). Si